Your browser doesn't support javascript.
loading
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial.
Jongsma, Maria M E; Aardoom, Martine A; Cozijnsen, Martinus A; van Pieterson, Merel; de Meij, Tim; Groeneweg, Michael; Norbruis, Obbe F; Wolters, Victorien M; van Wering, Herbert M; Hojsak, Iva; Kolho, Kaija-Leena; Hummel, Thalia; Stapelbroek, Janneke; van der Feen, Cathelijne; van Rheenen, Patrick F; van Wijk, Michiel P; Teklenburg-Roord, Sarah T A; Schreurs, Marco W J; Rizopoulos, Dimitris; Doukas, Michail; Escher, Johanna C; Samsom, Janneke N; de Ridder, Lissy.
Afiliação
  • Jongsma MME; Paediatric Gastroenterology, Erasmus MC Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Aardoom MA; Paediatric Gastroenterology, Erasmus MC Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Cozijnsen MA; Paediatric Gastroenterology, Erasmus MC Sophia Children's Hospital, Rotterdam, The Netherlands.
  • van Pieterson M; Paediatric Gastroenterology, Erasmus MC Sophia Children's Hospital, Rotterdam, The Netherlands.
  • de Meij T; Paediatric Gastroenterology, University Medical Center Amsterdam-Location VUmc, Amsterdam, The Netherlands.
  • Groeneweg M; Paediatrics, Maasstad Hospital, Rotterdam, The Netherlands.
  • Norbruis OF; Paediatrics, Isala Hospital, Zwolle, The Netherlands.
  • Wolters VM; Paediatric Gastroenterology, Utrecht Medical Center/Wilhelmina Children's Hospital, Utrecht, The The Netherlands.
  • van Wering HM; Paediatrics, Amphia Hospital, Breda, The Netherlands.
  • Hojsak I; Referral centre for Paediatric Gastroenterology and Nutrition, Children's Hospital Zagreb, Zagreb, Croatia.
  • Kolho KL; University JJ Strossmayer, School of Medicine Osijek, Osijek, Croatia.
  • Hummel T; Paediatric Gastroenterology, Children's Hospital, University of Tampere, Helsinki, Finland.
  • Stapelbroek J; Tampere University, Tampere, Finland.
  • van der Feen C; Paediatrics, Medical Spectrum Twente, Enschede, The Netherlands.
  • van Rheenen PF; Paediatrics, Catharina Hospital, Eindhoven, The Netherlands.
  • van Wijk MP; Paediatrics, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
  • Teklenburg-Roord STA; Paediatric Gastroenterology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
  • Schreurs MWJ; Paediatric Gastroenterology, University Medical Center Amsterdam-Location VUmc, Amsterdam, The Netherlands.
  • Rizopoulos D; Paediatrics, Isala Hospital, Zwolle, The Netherlands.
  • Doukas M; Immunology, Erasmus MC, Rotterdam, The Netherlands.
  • Escher JC; Biostatistics, Erasmus MC, Rotterdam, The Netherlands.
  • Samsom JN; Pathology, Erasmus MC, Rotterdam, The Netherlands.
  • de Ridder L; Paediatric Gastroenterology, Erasmus MC Sophia Children's Hospital, Rotterdam, The Netherlands.
Gut ; 71(1): 34-42, 2022 01.
Article em En | MEDLINE | ID: mdl-33384335
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doença de Crohn / Infliximab Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Limite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Gut Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doença de Crohn / Infliximab Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Limite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Gut Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda